Xingxing Tang

1.0k total citations · 1 hit paper
34 papers, 857 citations indexed

About

Xingxing Tang is a scholar working on Electrical and Electronic Engineering, Cancer Research and Surgery. According to data from OpenAlex, Xingxing Tang has authored 34 papers receiving a total of 857 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Electrical and Electronic Engineering, 10 papers in Cancer Research and 8 papers in Surgery. Recurrent topics in Xingxing Tang's work include Cancer, Lipids, and Metabolism (7 papers), Perovskite Materials and Applications (7 papers) and Bladder and Urothelial Cancer Treatments (6 papers). Xingxing Tang is often cited by papers focused on Cancer, Lipids, and Metabolism (7 papers), Perovskite Materials and Applications (7 papers) and Bladder and Urothelial Cancer Treatments (6 papers). Xingxing Tang collaborates with scholars based in China, Australia and Norway. Xingxing Tang's co-authors include Runfeng Chen, Wei Huang, Wenzhen Lv, Ling Li, Ligang Xu, Rui Zhu, Yinghong Wu, Peng Du, Jie Yuan and Chao Zheng and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and Chemical Communications.

In The Last Decade

Xingxing Tang

31 papers receiving 851 citations

Hit Papers

Improving the Stability o... 2019 2026 2021 2023 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xingxing Tang China 12 548 516 94 92 90 34 857
Arto Hiltunen Finland 16 403 0.7× 363 0.7× 126 1.3× 113 1.2× 24 0.3× 26 787
Yuyun Sun China 13 200 0.4× 380 0.7× 52 0.6× 27 0.3× 79 0.9× 36 626
Xiaodong Feng China 17 387 0.7× 234 0.5× 91 1.0× 34 0.4× 106 1.2× 51 878
Chunyang Lu China 17 311 0.6× 212 0.4× 89 0.9× 22 0.2× 121 1.3× 35 765
M.L. Marcos Spain 18 261 0.5× 250 0.5× 112 1.2× 48 0.5× 30 0.3× 41 799
Chenlu He China 15 221 0.4× 308 0.6× 38 0.4× 30 0.3× 55 0.6× 43 872
Chan Uk Lee South Korea 16 445 0.8× 346 0.7× 69 0.7× 41 0.4× 17 0.2× 32 768
Qipeng Liu China 16 719 1.3× 886 1.7× 67 0.7× 36 0.4× 187 2.1× 39 1.5k
Nao Takano Japan 16 392 0.7× 196 0.4× 22 0.2× 36 0.4× 88 1.0× 42 704

Countries citing papers authored by Xingxing Tang

Since Specialization
Citations

This map shows the geographic impact of Xingxing Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingxing Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingxing Tang more than expected).

Fields of papers citing papers by Xingxing Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingxing Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingxing Tang. The network helps show where Xingxing Tang may publish in the future.

Co-authorship network of co-authors of Xingxing Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Xingxing Tang. A scholar is included among the top collaborators of Xingxing Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingxing Tang. Xingxing Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Xingxing, et al.. (2025). TNF Signaling Pathway Is the Key Pathway Regulated by Disitamab Vedotin in Bladder Cancer Cells. Current Issues in Molecular Biology. 47(5). 369–369.
2.
Tang, Xingxing, et al.. (2024). Investigating the clinical predictive utility of inflammatory markers and nomogram development in colorectal cancer patients with malnutrition. Frontiers in Nutrition. 11. 1442094–1442094. 2 indexed citations
3.
Zhai, Zhao, Shuo Wang, Yudong Cao, et al.. (2024). Pan-Cancer Analysis Reveals the Potential of PLOD1 as a Prognostic and Immune Biomarker for Human Cancer. Biomedicines. 12(12). 2653–2653.
4.
Yang, Yang, Xiaofei Wang, Shuangchen Chen, et al.. (2024). PTBP1-mediated biogenesis of circATIC promotes progression and cisplatin resistance of bladder cancer. International Journal of Biological Sciences. 20(9). 3570–3589. 11 indexed citations
5.
Li, Yanping, et al.. (2023). Hyperprogressive disease in non-small cell lung cancer after PD-1/PD-L1 inhibitors immunotherapy: underlying killer. Frontiers in Immunology. 14. 1200875–1200875. 3 indexed citations
6.
Tang, Xingxing, Qiang Zhao, Jia Liu, et al.. (2021). The compound AST-003 could effectively promote apoptosis of renal cell carcinoma cells in vitro. Translational Cancer Research. 10(5). 2120–2133. 1 indexed citations
7.
Liu, Nannan, et al.. (2021). Metal–organic framework-based micropipette is a metal ion responsive nanochannel after adsorbing H2S. Chemical Communications. 57(58). 7152–7155. 11 indexed citations
8.
Wang, Shuo, Yong Yang, Yudong Cao, Xingxing Tang, & Peng Du. (2020). Androgen downregulation of miR-760 promotes prostate cancer cell growth by regulating IL6. Asian Journal of Andrology. 23(1). 85–90. 10 indexed citations
9.
Tang, Xingxing, et al.. (2020). The diagnostic and prognostic value of nuclear matrix protein 22 in bladder cancer. Translational Cancer Research. 9(11). 7174–7182. 6 indexed citations
10.
Tang, Xingxing, et al.. (2020). Diagnostic Value of Inflammatory Factors in Pathology of Bladder Cancer Patients. Frontiers in Molecular Biosciences. 7. 575483–575483. 23 indexed citations
11.
Qian, Yue, et al.. (2019). Nanopore-based DNA Supersandwich Structure for Detection of Streptavidin. Chemical Research in Chinese Universities. 35(5). 837–841. 4 indexed citations
12.
Lv, Wenzhen, Honglei Wang, Xingxing Tang, et al.. (2018). Tunable Nonvolatile Memory Behaviors of PCBM–MoS2 2D Nanocomposites through Surface Deposition Ratio Control. ACS Applied Materials & Interfaces. 10(7). 6552–6559. 52 indexed citations
13.
Yuan, Jie, Lu Jin, Runfeng Chen, et al.. (2018). Eaton's reagent assisted aromatic C–C coupling of carbazoles for optoelectronic applications. New Journal of Chemistry. 42(18). 14704–14708. 11 indexed citations
14.
Wang, Honglei, Wenzhen Lv, Xingxing Tang, et al.. (2017). Two-Dimensional Perovskites and Their Applications on Optoelectronic Devices. Huaxue jinzhan. 29(8). 859. 3 indexed citations
15.
Wang, Shuo, et al.. (2017). Comparison of Efficiency of Video Endoscopy and Open Inguinal Lymph Node Dissection. Anticancer Research. 37(8). 4623–4628. 19 indexed citations
16.
Du, Peng, et al.. (2017). Reduced Expression of Metastasis Suppressor-1 (MTSS1) Accelerates Progression of Human Bladder Uroepithelium Cell Carcinoma. Anticancer Research. 37(8). 4499–4505. 10 indexed citations
17.
Tang, Xingxing, et al.. (2017). The clinical use of neutrophil-to-lymphocyte ratio in bladder cancer patients: a systematic review and meta-analysis. International Journal of Clinical Oncology. 22(5). 817–825. 51 indexed citations
18.
Quan, Chuye, Yuhui Ma, Yumin Han, et al.. (2015). Effect of Nd substitution for Ca on crystal structure, optical and magnetic properties of multiferroic Bi0.9Ca0.1FeO3. Journal of Alloys and Compounds. 635. 272–277. 13 indexed citations
19.
Tang, Xingxing. (2013). Determination of total iron in iron ore by stannous chloride-methylene blue-potassium dichromate mercury-free titration. Metallurgical Analysis. 2 indexed citations
20.
Qin, Wei, et al.. (1994). [Risk factors of prostate cancer--a matched case-control study].. PubMed. 25(1). 87–90. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026